Mostrar el registro sencillo del ítem

In danger: HIV vaccine research and development in Europe

dc.rights.licenseopenen_US
dc.contributor.authorTATOUD, Roger
dc.contributor.authorLEVY, Yves
dc.contributor.authorLE GRAND, Roger
dc.contributor.authorALCAMI, Jose
dc.contributor.authorBARBARESCHI, Giorgio
dc.contributor.authorBRANDER, Christian
dc.contributor.authorCARA, Andrea
dc.contributor.authorCOMBADIERE, Behazine
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorDABIS, Francois
dc.contributor.authorFIDLER, Sarah
dc.contributor.authorHANKE, Tomas
dc.contributor.authorHERRERA, Carolina
dc.contributor.authorKARLSSON HEDESTAM, Gunilla B
dc.contributor.authorKUIPERS, Hester
dc.contributor.authorMCCORMACK, Sheena
dc.contributor.authorMOOG, Christiane
dc.contributor.authorPANTALEO, Giuseppe
hal.structure.identifierStatistics In System biology and Translational Medicine [SISTM]
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRICHERT, Laura
dc.contributor.authorSANDERS, Rogier W
dc.contributor.authorSHATTOCK, Robin
dc.contributor.authorSTREECK, Hendrik
hal.structure.identifierStatistics In System biology and Translational Medicine [SISTM]
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorTHIEBAUT, Rodolphe
dc.contributor.authorTRKOLA, Alexandra
dc.contributor.authorUEBERLA, Klaus
dc.contributor.authorVAN GILLS, Marit J
dc.contributor.authorWAGNER, Ralf
dc.contributor.authorWEISSENHORN, Winfried
dc.contributor.authorYAZDANPANAH, Yazdan
dc.contributor.authorSCARLATTI, Gabriella
dc.contributor.authorLELIEVRE, Jean Daniel
dc.date.accessioned2025-05-26T07:51:11Z
dc.date.available2025-05-26T07:51:11Z
dc.date.issued2025-04-08
dc.identifier.issn2767-3375en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/206710
dc.description.abstractEnHighly effective antiretroviral-based HIV prevention plays an important role in ending the global HIV/AIDS epidemic. However, the sustainable control of the epidemic is hampered by unequal access to prevention options, including HIV testing, alongside with drug resistance and ongoing barriers to accessing sustainable HIV treatment. Therefore, an HIV vaccine, combined with effective prevention and treatment, remains an absolute necessity to control the epidemic. Yet, the recent discontinuation of four major vaccine efficacy studies is raising concerns about the future of HIV vaccine research and development globally, and particularly in the European region where funding for vaccine research and development has shrinked. This viewpoint emphasises that supporting HIV vaccine research and development at the European level remains crucial: it is not only necessary to control the epidemic, but it promotes innovation, strengthens health security, epidemic preparedness, and health sovereignty while contributing to the economies of European nations.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.title.enIn danger: HIV vaccine research and development in Europe
dc.title.alternativePLOS Glob Public Healthen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1371/journal.pgph.0004364en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed40198605en_US
bordeaux.journalPLOS Global Public Healthen_US
bordeaux.pagee0004364en_US
bordeaux.volume5en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue4en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.institutionINRIAen_US
bordeaux.teamGHIGS_BPHen_US
bordeaux.teamSISTM_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDInstitut de Recherche pour le Développementen_US
bordeaux.identifier.funderIDBill and Melinda Gates Foundationen_US
bordeaux.identifier.funderIDNational Institutes of Healthen_US
bordeaux.identifier.funderIDNational Institute of Allergy and Infectious Diseasesen_US
bordeaux.identifier.funderIDInternational AIDS Societyen_US
hal.identifierhal-05084236
hal.version1
hal.date.transferred2025-05-26T07:51:16Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=PLOS%20Global%20Public%20Health&rft.date=2025-04-08&rft.volume=5&rft.issue=4&rft.spage=e0004364&rft.epage=e0004364&rft.eissn=2767-3375&rft.issn=2767-3375&rft.au=TATOUD,%20Roger&LEVY,%20Yves&LE%20GRAND,%20Roger&ALCAMI,%20Jose&BARBARESCHI,%20Giorgio&rft.genre=article


Archivos en el ítem

Thumbnail
Nombre:
BPH_PLOSGPH_2025_Tatoud.pdf
Tamaño:
689.2Kb
Formato:
PDF
Ver/Abrir
Thumbnail
Nombre:
license_rdf
Tamaño:
914bytes
Formato:
application/rdf+xml
Ver/Abrir

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem